196 related articles for article (PubMed ID: 7707515)
1. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
Song CZ; Loewenstein PM; Green M
J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
[TBL] [Abstract][Full Text] [Related]
2. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
Tsang SX; Morris GF; Lu M; Morris CB
Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
[TBL] [Abstract][Full Text] [Related]
3. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
4. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.
Parker SF; Felzien LK; Perkins ND; Imperiale MJ; Nabel GJ
J Virol; 1997 Mar; 71(3):2004-12. PubMed ID: 9032332
[TBL] [Abstract][Full Text] [Related]
5. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
Laspia MF; Rice AP; Mathews MB
Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
7. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
9. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
10. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
11. HIV Tat protein requirements for transactivation and repression of transcription are separable.
Brown JA; Howcroft TK; Singer DS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):9-16. PubMed ID: 9436753
[TBL] [Abstract][Full Text] [Related]
12. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
13. Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency.
Drysdale CM; Pavlakis GN
J Virol; 1991 Jun; 65(6):3044-51. PubMed ID: 2033665
[TBL] [Abstract][Full Text] [Related]
14. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat.
Liu YZ; Latchman DS
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):155-8. PubMed ID: 9078256
[TBL] [Abstract][Full Text] [Related]
15. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
[TBL] [Abstract][Full Text] [Related]
16. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
17. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
18. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
[TBL] [Abstract][Full Text] [Related]
19. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.
Veschambre P; Roisin A; Jalinot P
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2235-45. PubMed ID: 9292011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
